The part-time course joined NDORMS at the start of October ready for the new cohort of 14 students who start today. The students usually come from a range of backgrounds, from clinicians to nurses, researchers working in industry and recent graduates.
Students are mainly based at Rewley House in Wellington Square where the majority of teaching takes place. The course comprises six taught modules taken over two to three years, and a dissertation project in the final three terms.
The course covers a wide range of topics, including clinical trials and experimental therapeutics, drug development, pharmacokinetics, biomarkers, personalised therapy and biological therapeutics. With the move to NDORMS, the course will expand to cover the development and application of novel therapies in orthopaedics, rheumatology and immunology.
The course is led by NDORMS Climax Professor of Therapeutics, Professor Duncan Richards, Professor Len Seymour from the Department of Oncology, and Dr Elaine Johnstone, Departmental Lecturer and ETT Co-Director.
On the new MSc coming to NDORMS, Professor Richards said ‘The purpose and content of this course are tightly aligned with our strategic objective of bringing new effective treatments to patients. We are really looking forward to working with Elaine and Len to evolve the course in this rapidly changing space and to maximizing its impact.’